Literature DB >> 10927739

Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus.

E Mylonakis1, M Paliou, T C Greenbough, T P Flaningan, N L Letvin, J D Rich.   

Abstract

Considering the lifelong implications of a positive human immunodeficiency virus (HIV) test result, physicians should be aware of the limitations of tests for HIV. A 43-year-old man had a reactive enzyme-linked immunosorbent assay and an indeterminate result on Western blot analysis. The results of subsequent enzyme-linked immunosorbent assay and Western blot tests were interpreted as positive, and the patient was informed that he had HIV infection. Persistently undetectable plasma HIV-1 RNA, combined with normal physical examination findings, CD4(+) cell count, and CD4/CD8 ratio, prompted further testing, which revealed that the patient was not infected with HIV. False-positive HIV test results are uncommon, but they can occur. In the appropriate clinical setting, follow-up and the use of other laboratory tests, such as determination of plasma viral load, may help identify such cases.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10927739     DOI: 10.1001/archinte.160.15.2386

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  9 in total

1.  An autoreactive antibody from an SLE/HIV-1 individual broadly neutralizes HIV-1.

Authors:  Mattia Bonsignori; Kevin Wiehe; Sebastian K Grimm; Rebecca Lynch; Guang Yang; Daniel M Kozink; Florence Perrin; Abby J Cooper; Kwan-Ki Hwang; Xi Chen; Mengfei Liu; Krisha McKee; Robert J Parks; Joshua Eudailey; Minyue Wang; Megan Clowse; Lisa G Criscione-Schreiber; M Anthony Moody; Margaret E Ackerman; Scott D Boyd; Feng Gao; Garnett Kelsoe; Laurent Verkoczy; Georgia D Tomaras; Hua-Xin Liao; Thomas B Kepler; David C Montefiori; John R Mascola; Barton F Haynes
Journal:  J Clin Invest       Date:  2014-03-10       Impact factor: 14.808

Review 2.  Human Ig knockin mice to study the development and regulation of HIV-1 broadly neutralizing antibodies.

Authors:  Laurent Verkoczy; Frederick W Alt; Ming Tian
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

Review 3.  Autoreactivity in HIV-1 broadly neutralizing antibodies: implications for their function and induction by vaccination.

Authors:  Laurent Verkoczy; Marilyn Diaz
Journal:  Curr Opin HIV AIDS       Date:  2014-05       Impact factor: 4.283

4.  Indeterminate human immunodeficiency virus Western blot profiles in ethiopians with discordant screening-assay results.

Authors:  Hailu Meles; Dawit Wolday; Arnaud Fontanet; Aster Tsegaye; Tesfaye Tilahun; Mathias Aklilu; Eduard Sanders; Tobias F Rinke De Wit
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

Review 5.  Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.

Authors:  Laurent Verkoczy
Journal:  Adv Immunol       Date:  2017       Impact factor: 3.543

Review 6.  Immunological tolerance as a barrier to protective HIV humoral immunity.

Authors:  Kristin Ms Schroeder; Amanda Agazio; Raul M Torres
Journal:  Curr Opin Immunol       Date:  2017-07-17       Impact factor: 7.486

7.  Breaching peripheral tolerance promotes the production of HIV-1-neutralizing antibodies.

Authors:  Kristin M S Schroeder; Amanda Agazio; Pamela J Strauch; Sean T Jones; Scott B Thompson; Michael S Harper; Roberta Pelanda; Mario L Santiago; Raul M Torres
Journal:  J Exp Med       Date:  2017-07-11       Impact factor: 14.307

8.  HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

Authors:  Gabriel Siracusano; Annamaria Finardi; Claudia Pastori; Vittorio Martinelli; Roberto Furlan; Lucia Lopalco
Journal:  Front Immunol       Date:  2021-11-02       Impact factor: 7.561

9.  Immune System Regulation in the Induction of Broadly Neutralizing HIV-1 Antibodies.

Authors:  Garnett Kelsoe; Laurent Verkoczy; Barton F Haynes
Journal:  Vaccines (Basel)       Date:  2014-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.